Friday, November 13, 2026

US Healthcare REIT Captures 180-Point Spread Selling at 7.9%, Buying at 9.5% Amid Global Real Estate Repricing

Community Healthcare Trust sold $20M in US properties at 7.9% cap rates while acquiring $122.5M at 9.1-9.75% returns, exploiting a 120-190 basis point spread as global institutional capital repositions. The transactions coincide with MSCI's February 2026 index rebalancing affecting 340+ securities worldwide. Healthcare real estate commands premium valuations internationally versus retail or office amid longer lease terms.

ViaNews Editorial Team

February 25, 2026

From our archive, published before source-traceability. How we work

Source Trace Score7 source documents7 with a live linkVerifiability: Strong
US Healthcare REIT Captures 180-Point Spread Selling at 7.9%, Buying at 9.5% Amid Global Real Estate Repricing
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Community Healthcare Trust completed $20M in US property sales at a 7.9% capitalization rate during Q4 2025, immediately redeploying proceeds into $122.5M of acquisitions yielding 9.1-9.75%. The 120-190 basis point spread reflects diverging global investor appetite between stabilized healthcare assets and new medical facilities with specialized operators.

The transactions align with MSCI's February 2026 global index rebalancing, which added or removed 340+ constituents across markets, redirecting institutional capital flows into real estate investment trusts worldwide. CFO David Dupuy said CHCT avoided share issuance, instead funding deals through asset recycling and credit capacity—a strategy mirroring approaches by European and Asian healthcare REITs navigating tighter equity markets.

CHCT's portfolio now carries a 7-year weighted average lease term, above the 5-6 year norms for US commercial property but below the 10-15 year healthcare leases common in Germany and Australia. The company targets $120M-$150M in annual acquisitions, matching its pre-pandemic pace when stock valuations supported accretive capital raises.

Medical real estate globally trades at premiums to retail or office properties, driven by structural demand from aging populations in developed markets. CHCT's 9.1-9.75% acquisition yields exceed current cap rates for US retail (7-8%) and office (8-9%) while remaining below the 10-12% returns available in emerging healthcare markets like Southeast Asia or Latin America.

The REIT is finalizing the sale of geriatric behavioral hospital operations, though timing remains uncertain as the buyer completes due diligence. Behavioral health facilities represent a niche within healthcare real estate, with limited comparable transaction data outside North America and select European markets.

Passive funds tracking MSCI indices execute mandatory trades during rebalancing periods, creating short-term pricing dislocations that active managers exploit. CHCT's ability to capture 180-point spreads between sales and purchases depends partly on these capital flow dynamics affecting global real estate securities.

Healthcare REITs in the US, UK, and Japan face similar fundamentals: operator-dependent performance, regulatory complexity, and demographic tailwinds offsetting commercial real estate headwinds. CHCT's strategy of selling stabilized assets while acquiring higher-yielding properties mirrors portfolio optimization tactics employed by healthcare property investors across developed markets.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score7 source documents7 with a live linkVerifiability: Strong
  1. [1]News articleYahoo Finance· February 18, 2026
    CHCT Reports Earnings
  2. [2]News articleYahoo Finance· February 18, 2026
    Texas Pacific Land Corporation Announces Fourth Quarter and Full Year 2025 Results
  3. [3]News articleYahoo Finance· February 23, 2026
    Earnings live: Hims & Hers stock slides, Domino's rises as investors await crucial update from Nvidia
  4. [4]News articleYahoo Finance· February 11, 2026
    MSCI Equity Indexes February 2026 Index Review
  5. [5]Press releaseGlobeNewswire· February 11, 2026
    OP Pohjola's Financial Statements Bulletin 1 January–31 December 2025: Another strong year for OP Pohjola – operating profit EUR 2,269 million
  6. [6]News articleYahoo Finance· February 12, 2026
    Public Storage Announces PS4.0™ — A New Era of Leadership, Growth and Value Creation
  7. [7]Press releaseGlobeNewswire· February 13, 2026
    Sumitomo Forestry Announces Strategic Combination with Tri Pointe Homes to Create a Leading U.S. Homebuilder
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com